Mesoblast (MESO) Cash & Equivalents Growth (1y) (2016 - 2025)
Mesoblast (MESO) Cash & Equivalents Growth (1y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 15.53% |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 90.42% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 17.50% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -4.13% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Mesoblast | 19.81 Bn | 19.68 Bn | - | 241.78% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 241.78% |
| Jun 30, 2025 | 156.59% |
| Dec 31, 2024 | -50.96% |
| Jun 30, 2024 | -11.72% |
| Dec 31, 2023 | 14.69% |
| Jun 30, 2023 | 17.98% |
| Mar 31, 2023 | -36.43% |
| Dec 31, 2022 | -28.71% |
| Sep 30, 2022 | -26.26% |
| Jun 30, 2022 | -55.84% |
| Mar 31, 2022 | -51.50% |
| Dec 31, 2021 | 22.34% |
| Sep 30, 2021 | 7.24% |
| Jun 30, 2021 | 5.84% |
| Mar 31, 2021 | 163.43% |
| Dec 31, 2020 | -4.70% |
| Sep 30, 2020 | 213.07% |
| Jun 30, 2020 | 156.47% |
| Mar 31, 2020 | -14.65% |
| Dec 31, 2019 | 5.62% |